UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 294

Sortiert nach

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Haematologica (Roma), 2012-11, Vol.97 (11), p.1761-1767

2012

Volltextzugriff (PDF)

Clinical value of molecular subtyping multiple myeloma using gene expression profiling

Leukemia, 2016-02, Vol.30 (2), p.423-430

2016

Volltextzugriff (PDF)

Effects of long-term nitrogen addition on phosphorus cycling in organic soil horizons of temperate forests

Biogeochemistry, 2018-11, Vol.141 (2), p.167-181

2018

Volltextzugriff (PDF)

Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

Leukemia, 2012-11, Vol.26 (11), p.2398-2405

2012

Volltextzugriff (PDF)

Inhibiting MEK in MAPK pathway-activated myeloma

Leukemia, 2016-04, Vol.30 (4), p.976-980

2016

Volltextzugriff (PDF)

Serial exome analysis of disease progression in premalignant gammopathies

Leukemia, 2014-07, Vol.28 (7), p.1548-1552

2014

Volltextzugriff (PDF)

Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia

Leukemia, 2014-04, Vol.28 (4), p.888-893

2014

Volltextzugriff (PDF)

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

Leukemia, 2014-12, Vol.28 (12), p.2410-2413

2014

Volltextzugriff (PDF)

Electroless Deposition and Structuring of Silver Electrodes in Closed Microfluidic Capillaries

Journal of microelectromechanical systems, 2011-04, Vol.20 (2), p.451-459

2011

Volltextzugriff (PDF)

Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma

Leukemia, 2015-12, Vol.29 (12), p.2418-2421

2015

Volltextzugriff (PDF)

Low voltage electroosmotic pump for high density integration into microfabricated fluidic systems

Microfluidics and nanofluidics, 2011-06, Vol.10 (6), p.1317-1332

2011

Volltextzugriff (PDF)

P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) (MONUMENTAL‐1)

HemaSphere, 2023-05, Vol.7 (S2), p.26-27

2023

Volltextzugriff (PDF)

AB1194 Serum cartilage oligomeric matrix protein compared to articular cartilage thickness in children with juvenile idiopathic arthritis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.706-706

2013

Volltextzugriff (PDF)

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma

Leukemia, 2015-08, Vol.29 (8), p.1713-1720

2015

Volltextzugriff (PDF)

OP0012 Chronic recurrent non-bacterial osteomyelitis in danish children

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.56-56

2013

Volltextzugriff (PDF)

Establishing traceability of photometric absorbance values for accurate measurements of the haemoglobin concentration in blood

Metrologia, 2013-10, Vol.50 (5), p.539-548

2013

Volltextzugriff (PDF)

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

Haematologica (Roma), 2013-07, Vol.98 (7), p.1147-1153

2013

Volltextzugriff (PDF)

Microfluidic Production and Application of Lipid Nanoparticles for Nucleic Acid Transfection

Methods in molecular biology (Clifton, N.J.), 2018-01, Vol.1792, p.193

2018

Volltextzugriff (PDF)

Microfluidic Assembly of Liposomes with Tunable Size and Coloading Capabilities

Methods in molecular biology (Clifton, N.J.), 2018-01, Vol.1792, p.205

2018

Volltextzugriff (PDF)

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Blood cancer journal (New York), 2016-07, Vol.6 (7), p.e453-e453

2016

Volltextzugriff (PDF)

Whole Exome Sequencing in Multiple Myeloma to Identify Somatic Single Nucleotide Variants and Key Translocations Involving Immunoglobulin Loci and MYC

Methods in molecular biology (Clifton, N.J.), 2018-01, Vol.1792, p.71

Walker, Brian A

2018

Volltextzugriff (PDF)

Analysis of Circulating Tumor DNA

Methods in molecular biology (Clifton, N.J.), 2018-01, Vol.1792, p.129

2018

Volltextzugriff (PDF)

Deep Profiling of the Immune System of Multiple Myeloma Patients Using Cytometry by Time-of-Flight (CyTOF)

Methods in molecular biology (Clifton, N.J.), 2018-01, Vol.1792, p.47

2018

Volltextzugriff (PDF)

Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Blood cancer journal (New York), 2016-09, Vol.6 (9), p.e471

2016

Volltextzugriff (PDF)

1 – 25 von 294

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Zeitschrift / SerieClinical Chemistry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(195)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Clinical value of molecular subtyping multiple myeloma using gene expression profiling

Effects of long-term nitrogen addition on phosphorus cycling in organic soil horizons of temperate forests

Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

Inhibiting MEK in MAPK pathway-activated myeloma

Serial exome analysis of disease progression in premalignant gammopathies

Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

Electroless Deposition and Structuring of Silver Electrodes in Closed Microfluidic Capillaries

Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma

Low voltage electroosmotic pump for high density integration into microfabricated fluidic systems

P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) (MONUMENTAL‐1)

AB1194 Serum cartilage oligomeric matrix protein compared to articular cartilage thickness in children with juvenile idiopathic arthritis

P42 HEALTH‐RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, FROM MONUMENTAL‐1

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma

OP0012 Chronic recurrent non-bacterial osteomyelitis in danish children

Establishing traceability of photometric absorbance values for accurate measurements of the haemoglobin concentration in blood

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

Microfluidic Production and Application of Lipid Nanoparticles for Nucleic Acid Transfection

Microfluidic Assembly of Liposomes with Tunable Size and Coloading Capabilities

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Whole Exome Sequencing in Multiple Myeloma to Identify Somatic Single Nucleotide Variants and Key Translocations Involving Immunoglobulin Loci and MYC

Analysis of Circulating Tumor DNA

Deep Profiling of the Immune System of Multiple Myeloma Patients Using Cytometry by Time-of-Flight (CyTOF)

Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Aktive Filter

Suchergebnisse filtern